In vivo anti-tumor efficacy of afucosylated anti-CS1 monoclonal antibody produced in glycoengineered Pichia pastoris
Year: 2015
Type: article
Source: Journal of Biotechnology
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W327289427
